BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 19553822)

  • 21. Prostate cancer update: 2006.
    Lin AM; Small EJ
    Curr Opin Oncol; 2007 May; 19(3):229-33. PubMed ID: 17414641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re: Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer.
    Brenner DJ; Hall EJ
    J Urol; 2006 Feb; 175(2):788-9; author reply 789. PubMed ID: 16407052
    [No Abstract]   [Full Text] [Related]  

  • 23. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer.
    Chrouser K; Leibovich B; Bergstralh E; Zincke H; Blute M
    J Urol; 2008 May; 179(5 Suppl):S7-S11. PubMed ID: 18405759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted focal therapy for prostate cancer: a review.
    Hou AH; Sullivan KF; Crawford ED
    Curr Opin Urol; 2009 May; 19(3):283-9. PubMed ID: 19357510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy.
    Leonardo C; Simone G; Papalia R; Franco G; Guaglianone S; Gallucci M
    Int J Urol; 2009 Jun; 16(6):584-6. PubMed ID: 19453762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ionizing radiation and bladder cancer].
    Prianichnikova MB
    Urol Nefrol (Mosk); 1996; (6):44-5. PubMed ID: 9036611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data.
    Abdel-Wahab M; Reis IM; Wu J; Duncan R
    Urology; 2009 Oct; 74(4):866-71. PubMed ID: 19628258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A population study of neutering status as a risk factor for canine prostate cancer.
    Bryan JN; Keeler MR; Henry CJ; Bryan ME; Hahn AW; Caldwell CW
    Prostate; 2007 Aug; 67(11):1174-81. PubMed ID: 17516571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?
    Klein EA; Ciezki J; Kupelian PA; Mahadevan A
    Urol Oncol; 2009; 27(1):67-71. PubMed ID: 19111801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher than expected association of clinical prostate and bladder cancers.
    Singh A; Kinoshita Y; Rovito PM; Landas S; Silberstein J; Nsouli I; Wang CY; Haas GP
    J Urol; 2008 May; 179(5 Suppl):S2-5. PubMed ID: 18405742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two cases of second bladder cancer after radiotherapy for prostate cancer].
    Numata K; Azuma K; Hashine K; Sumiyoshi Y
    Nihon Hinyokika Gakkai Zasshi; 2005 Mar; 96(3):466-9. PubMed ID: 15828265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical analysis of double cancer involving bladder and prostate].
    Yumura Y; Oogo Y; Takase K; Kato Y; Hamano A; Noguchi S; Fukuda M; Satomi Y
    Hinyokika Kiyo; 2006 Apr; 52(4):255-8. PubMed ID: 16686351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic inflammation and bladder cancer.
    Michaud DS
    Urol Oncol; 2007; 25(3):260-8. PubMed ID: 17483025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor in bladder reservoir after gastrocystoplasty.
    Castellan M; Gosalbez R; Perez-Brayfield M; Healey P; McDonald R; Labbie A; Lendvay T
    J Urol; 2007 Oct; 178(4 Pt 2):1771-4; discussion 1774. PubMed ID: 17707009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic pelvic sling placement facilitates optimum therapeutic radiotherapy delivery in the management of pelvic malignancy.
    Joyce M; Thirion P; Kiernan F; Byrnes C; Kelly P; Keane F; Neary P
    Eur J Surg Oncol; 2009 Apr; 35(4):348-51. PubMed ID: 18358678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prostate cancer: what role for curative radiotherapy in elderly?].
    Nguyen TD; Azria D; Brochon D; Poortmans P; Miller RC
    Cancer Radiother; 2009 Oct; 13(6-7):623-7. PubMed ID: 19695936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does muscle invasive bladder cancer following pelvic radiotherapy portend worse prognosis? A seer-based study.
    Natale C; Leinwand G; Zeineddine F; Silberstein JL; Krane LS
    Cancer Treat Res Commun; 2020; 24():100177. PubMed ID: 32454387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate cancer in patients with the bladder exstrophy-epispadias complex: insights and outcomes.
    Berkowitz J; Carter HB; Gearhart JP
    Urology; 2008 Jun; 71(6):1064-6. PubMed ID: 18308374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of alpha-blockers in the management of lower urinary tract symptoms in prostate cancer patients treated with radiation therapy.
    Crawford ED; Kavanagh BD
    Am J Clin Oncol; 2006 Oct; 29(5):517-23. PubMed ID: 17023790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer.
    Mazzucchelli R; Barbisan F; Santinelli A; Scarpelli M; Galosi AB; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R
    Urology; 2009 Aug; 74(2):385-90. PubMed ID: 19501882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.